Results 101 to 110 of about 2,861,094 (164)

HLA-DR Negative [PDF]

, 2020
openaire   +1 more source

Expansion of activated T-lymphocytes (CD3+HLA/DR+) detectable in early stages of HIV1-infection [PDF]

, 1990
Bogner, Johannes R., Matuschke, A., Heinrich, B., Goebel, Frank-Detlef, Schreiber, M. A., Nerl, C.   +5 more
core   +1 more source

HLA-DR and Sarcoidosis

SARUKOIDOJISU KENKYUKAISHI (The Japanese journal of sarcoidosis), 1985
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

HLA-DR is a procoagulant

Biochemical and Biophysical Research Communications, 1991
Numerous incidents of thromboembolic complications have been documented in cancer patients and in recipients of mismatched organ transplants. Tumor procoagulants have also been implicated in the process of metastasis. Two protein bands of 35,000 and 28,000 daltons isolated from human ovarian carcinoma possessed procoagulant activity.
M, Chelladurai, K V, Honn, D A, Walz
openaire   +2 more sources

Targeting HLA-DR

Leukemia & Lymphoma, 2009
The MHC class II human leukocyte antigens (HLAs) are 60-kDa transmembrane αβ heterodimers expressed on the cell surface of antigen presenting cells.
Kevin, Tay, Kieron, Dunleavy, Wyndham H, Wilson   +2 more
openaire   +2 more sources

???????????????????? ?????????????????? HLA-DR ??????????????????, ???????????? ???????????????????????????????????? ?????????????????????? ?? ?????????????????????????????? ?????????????????? ???????????????????? ???????????? ?????? ??????????????????

2019
???????? ?????????????????????????? ???????????????? ????????????????, ?????? ?????????????????? ?????????? ???????????????????? ???????????? ?????? ??????????????????, ???? ?????????? ???? ??????????????. ?? ???????????? ???????????????????????? ?????????????? ?????????????????? ?????????????????? ???????????????????????? HLA-DR ?? ????????????????????
H. Renz, B. Gierten
openaire   +3 more sources

HLA-DR TYPING BY RADIOIMMUNOASSAY

Transplantation, 1980
A radioimmunoassay procedure is described by which peripheral blood lymphocytes can be typed for HLA-DR specificities. The major advantages of this method are the following: simple and reproducible procedure, no need for B lymphocyte separation, no need for optimal viability, and no need for preabsorption of antisera with platelets.
R, Tosi, N, Tanigaki, D, Centis, P L, Rossi, G, Alfano, G B, Ferrara, D, Pressman   +6 more
openaire   +2 more sources

HLA‐DR and monoclonal gammopathy

Tissue Antigens, 1982
The frequencies of the HLA‐DR antigens were compared in 3 groups: a group of 33 patients with multiple myeloma (MM) or Morbus Waldenström (MW); a group of 34 persons with benign monoclonal gammopathy (BMG); and a group of 118 healthy controls. No statistically significant associations were observed.
L, Muylle, D, De Smet, J, Cole, M E, Peetermans   +3 more
openaire   +2 more sources

Crystallization of HLA-DR antigens

Research in Immunology, 1991
The class II major histocompatibility antigens HLA-DR1, DR2, DR3, DR4, DR7 and DR8 were purified by immunoaffinity chromatography from homozygous human B lymphoblastoid cell lines. The purified, detergent-soluble molecules were cleaved with the protease papain to remove the hydrophobic transmembrane regions and cytoplasmic tails. Crystals were obtained
J C, Gorga, J H, Brown, T, Jardetzky, D C, Wiley, J L, Strominger   +4 more
openaire   +2 more sources

HLA-DR meets ERK

Blood, 2010
In this issue of Blood, Stein and colleagues present a novel mechanism by which MHC class II antibodies induce apoptosis in lymphoid malignancies. These are important findings that provide fresh insight into a common antibody target.
Erin, Hertlein, John C, Byrd
openaire   +2 more sources